Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg

Product Details
Application: Internal Medicine
Usage Mode: For oral administration
Suitable for: Elderly, Adult
Manufacturer/Factory, Trading Company
Diamond Member Since 2022

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Type of Ownership
Limited Company
  • Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg
  • Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg
  • Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg
  • Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg
  • Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg
  • Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg
Find Similar Products

Basic Info.

Model NO.
300mg
State
Solid
Shape
Tablet
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
Guoyaozhunzi
Standard
USP
Market 1
Foreign
Market 2
Domestic
Transport Package
Bottle with Box in Carton
Specification
300mg
Trademark
Manufacturer
Origin
P. R. China
HS Code
3004909099
Production Capacity
10 Million Boxes/Year

Product Description

Tenofovir Disoproxil Fumarate 300mg Tablets is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in patients weighing 30 kg or more.
Tenofovir Disoproxil Fumarate 300mg Tablets is indicated for the treatment of chronic hepatitis B in adults and in adolescents 12 to 18 years of age and weighing at least 35 kg.

Tenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mgTenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mgTenofovir Disoproxil Fumarate Tablet (TDF) Oral Dosage, USP 300mg

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier